In the pharma industry, it’s almost reflexive to tap an MD for the role of Vice President of Medical Affairs. After all, Medical Affairs serves as the bridge between clinical research, regulatory compliance, marketing, and real-world evidence — all areas where deep medical knowledge is a valuable asset. But here’s the truth few want to say out loud: appointing an MD as head of Medical Affairs isn’t always the best move.
Today’s Medical Affairs function is not just about scientific rigor — it’s about strategy, cross-functional communication, data fluency, patient-centricity, and commercial awareness. And too often, an MD leading Medical Affairs brings clinical tunnel vision and an insufficient understanding of how the pharmaceutical industry works.
Here’s why it may be wiser to hire someone with broad industry experience instead.
1. Medical Affairs Is No Longer a Support Function — It’s a Strategic One
Medical Affairs is no longer just the “scientific arm” of the company; it now steps in to support sales representatives with data and helps answer questions from healthcare providers. It’s now central to strategic planning, regulatory navigation, lifecycle management, and stakeholder engagement.
Someone with broad industry experience spanning regulatory, commercial, real-world evidence (RWE), market access, and policy will better understand how to integrate Medical Affairs into the company’s broader objectives. An MD may understand the science but often lacks the practical, political, and commercial experience to drive enterprise-level impact.
2. Clinical Expertise Does Not Equal Leadership or Strategic Acumen
Medical school trains individuals to diagnose and treat patients — not to lead cross-functional teams, develop medical launch strategies, or manage product portfolios. While an MD may be exceptional at interpreting data, that doesn’t mean they can:
- Build consensus across commercial, R&D, and compliance teams
- Set priorities in a resource-constrained environment
- Understand the evolving payer landscape
- Speak the language of both MSLs and marketers
Meanwhile, a seasoned pharma executive with exposure to diverse roles across the value chain is often better prepared to lead, influence, and anticipate the downstream consequences of medical decisions.
3. Bias Toward Science Can Lead to a Disconnect From Business Realities
An MD may overvalue clinical complexity and undervalue clarity — often leading to overly academic medical strategies that don’t align with market needs. They may struggle with the necessary give-and-take between medical integrity and commercial urgency. The result? Delays in decision-making, overly cautious communications, and a Medical Affairs team that’s perceived as a bottleneck.
In contrast, an executive with industry experience knows how to make science actionable, how to frame data for different audiences, and when to push back versus collaborate. They understand that the correct data in the proper context is more valuable than all the data.
4. Medical Affairs Must Now Understand the Patient’s Voice — Not Just the Provider’s
Pharma is (finally) becoming more patient-centric. Medical Affairs is increasingly responsible for incorporating patient insights, tracking outcomes data, and shaping narratives that reflect patient experience. Many doctors come from academic or hospital settings where the patient is an object of treatment rather than a source of insight.
Someone with broad exposure to advocacy groups, digital health, patient-reported outcomes, or real-world data is often better equipped to embed the patient perspective in scientific and regulatory communications.
5. Cross-Functional Respect Comes From Industry Fluency, Not Credentials
In pharma companies, cross-functional respect is earned through results and strategic clarity — not degrees. A VP of Medical Affairs who understands the language and KPIs of commercial, regulatory, HEOR and market access will be taken seriously across the organization.
An MD with limited industry exposure might hold the title but not the influence.
Hire for Impact, Not Pedigree
This isn’t to say MDs can’t thrive in Medical Affairs leadership. Some do — especially those who’ve taken the time to immerse themselves in the entire lifecycle of drug development, commercialization, and post-launch engagement.
But if you’re hiring for your next VP of Medical Affairs, think beyond the letters after their name. Look for someone who knows how to align science with strategy, who understands regulatory nuances and market realities, and who can inspire both MSLs and C-suite leaders. That person may not be a doctor — but they may be precisely who your organization needs.
The future of Medical Affairs is about connection, integration, and actionable insight. Choose a leader who brings the whole industry with them — not just the clinic.

